GlycoMimetics Total Assets 1970-1969 | GLYC

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

GlycoMimetics total assets from 1970 to 1969. Total assets can be defined as the sum of all assets on a company's balance sheet.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

GlycoMimetics total assets from 1970 to 1969. Total assets can be defined as the sum of all assets on a company's balance sheet.

Related Stocks
Company Name	Market Cap
Chugai Pharmaceutical (CHGCY)	$76.6B
Zoetis (ZTS)	$69B
Takeda Pharmaceutical (TAK)	$46.7B
Daiichi Sankyo, - (DSNKY)	$41.7B
BeOne Medicines - (ONC)	$27.4B
Sandoz Group AG (SDZNY)	$24.6B
Summit Therapeutics (SMMT)	$18.6B
Merck (MKKGY)	$17.2B
Shionogi (SGIOY)	$14.2B
United Therapeutics (UTHR)	$13.3B
Neurocrine Biosciences (NBIX)	$13.2B
Orion OYJ (ORINY)	$11B
IPSEN (IPSEY)	$10.3B
Stevanato Group S.p.A (STVN)	$7.6B
Corcept Therapeutics (CORT)	$7.6B
Madrigal Pharmaceuticals (MDGL)	$7B
Grifols, S.A (GRFS)	$6.7B
Ionis Pharmaceuticals (IONS)	$6.6B
Hikma Pharmaceuticals Plc (HKMPF)	$6.2B
Ono Pharmaceutical (OPHLF)	$5.1B
Soleno Therapeutics (SLNO)	$4.1B
Crinetics Pharmaceuticals (CRNX)	$3B
Hypermarcas (HYPMY)	$3B
Catalyst Pharmaceuticals (CPRX)	$2.7B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.6B
NewAmsterdam Pharma (NAMS)	$2.4B
Centessa Pharmaceuticals (CNTA)	$1.9B
BioCryst Pharmaceuticals (BCRX)	$1.8B
Ocular Therapeutix (OCUL)	$1.8B
ARS Pharmaceuticals (SPRY)	$1.7B